The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:1271-1273 October 26, 2000 Number 17
NextNext

Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Wong, C. S.
-PubMed Citation
To the Editor: Wong et al. (June 29 issue)1 report an association between antibiotic treatment in children with acute diarrhea caused by Escherichia coli O157:H7 and the development of the hemolytic–uremic syndrome. In Chile, shigella species cause 30 percent of cases of bloody diarrhea in children and enterohemorrhagic strains of E. coli cause 37 percent of such cases2 — a situation that may also be common in developing countries. For children with acute bloody diarrhea in these countries, the most widely accepted recommendation is to obtain a stool culture and initiate empirical antibiotic treatment for shigella, because appropriate treatment shortens . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.